Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
The incidence of cytarabine-induced pericarditis is rare. So far, only a few cases have been reported worldwide.
Description of the case
We are reporting a case of a 25-year-old male with acute myeloid leukemia (AML M2a) on chemotherapy who developed acute pericarditis after the administration of a cytarabine-containing regimen. The symptoms gradually improved after symptomatic treatment with steroids and other drugs.
This case demonstrates that, although pericarditis induced by cytarabine is rare, early recognition of this potentially life-threatening complication and appropriate management will usually result in the patient’s recovery.
KeywordsCytarabine Acute myeloid leukemia Pericarditis
- 3.O’Donnell MR, Tallman MS, Abboud CN et al (2017) Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 15(7):926–857Google Scholar
- 4.Pfizer (2014) Idamycin PFS (idarubicin hydrochloride injection). Prescribing information. Pfizer, New York, NYGoogle Scholar